MISSION: To Develop Novel Therapeutics for Alzheimer's Disease and Other CNS Disorders

Cenna Biosciences is a biopharmaceutical company dedicated to the discovery and development of novel drugs to prevent and treat Alzheimer's disease (AD). Cenna was founded in 2006 as a California C-corporation to translate over a decade's academic research at the University of California San Diego (UCSD) by the inventors of the technology. The research to date has been funded by non-diluting NIH and other grants.